Background: Focal cortical dysplasia (FCD) is recognized as the major cause of focal intractable epilepsy in childhood. Various factors influencing postsurgical seizure outcome in pediatric patients with FCD have been reported.
general epilepsy surgery variables are reported to be significant predictors of favorable postsurgical outcome: early indication for surgery, 8, 11 regional ictal EEG patterns, 12 detection of MRI lesion, 8, 13 and circumscribed resection. 8, 9 Temporal location of the surgery 9, 12, 14 and histopathologic types of dysplastic lesions (Krsek et al., submitted) 9, 13 were found to be important in FCD cases. Complete excision of the dysplastic cortex is often attributed to the contribution of intracranial EEG monitoring, 5, 15, 16 MRI, 6, 17, 18 both MRI and intracranial EEG, 19 -21 or intraoperative histopathology. 22 However, the results remain highly controversial. Few studies report long-term seizure outcome after surgery for FCD. 6, 11, 18, 21, 22 To address these issues we analyzed clinical, EEG, MRI, neuropsychological, surgical, and histopathologic data in relation to seizure outcome in a large cohort of children with histologically proven mMCD/FCD including 113 subjects with at least 5 years of postoperative follow-up.
METHODS Patient selection. Patients who underwent resective epilepsy surgery at the Miami Children's Hospital from March 1986 to June 2006 were retrospectively reviewed. Only subjects with a definite histologic diagnosis of mMCD/FCD were selected. Subjects with tuberous sclerosis complex, benign brain tumors, polymicrogyria, nodular heterotopia, Sturge-Weber syndrome, and hemimeganencephaly were not included. We did not exclude patients with hippocampal sclerosis and a history of perinatal brain insults coexisting with mMCD/FCD. Two hundred subjects from a population of 567 patients operated on during this period met the above-mentioned criteria. Of these, 51 patients were excluded because they were either lost to follow-up (n ϭ 21) or were postoperatively followed for less than 2 years (n ϭ 30). A total of 149 patients were retained for analysis.
Presurgical evaluation.
A complete history and a neurologic examination were obtained in every patient. All patients underwent preoperative scalp video EEG using the standard 10 -20 system of electrodes with additional electrodes applied in selected cases. Interictal epileptiform discharges and ictal EEG patterns were classified as either regional (appearing exclusively over a single lobe or in two contiguous regions such as centroparietal discharges) or non-regional (e.g., multilobar, hemispheric, or generalized). Patients with multiple ictal EEG patterns (such as regional and not-lateralized patterns) were always considered nonregional.
MRI scans of patients imaged at 1.5-Tesla including FLAIR sequences (n ϭ 108) were rigorously reevaluated. The remaining 41 children were either imaged at 0.3-Tesla or did not have available presurgical MRI data; their MRI results were excluded from the analysis. MRI data were re-evaluated independently by three experienced investigators (P.K., B.M., and E.P.J.).
Presence of hippocampal sclerosis (HS) was evaluated based on combined histopathologic and MRI criteria. We confirmed the diagnosis of HS from the histopathologic findings or MRI evidence of hippocampal atrophy and signal intensity change if there was insufficient tissue for pathologic analysis.
Presurgical neuropsychological data were reevaluated in 95 patients. For the purpose of the study, global functional ranking was determined because heterogeneous neuropsychological batteries had been utilized over the years in the assessment of the cases and also because some of the subjects could not be examined with common psychometric instruments due to pervasive intellectual or developmental impairments. The following categories of the ranking based on standard scores (SS) were distinguished: SS 1: moderate to severe impairment, IQ Յ59; SS 2: mild impairment, IQ 60 -69; SS 3: borderline intelligence, IQ 70 -79; SS 4: low average intelligence and above, IQ Ն80.
Surgical procedures and completeness of the resections. Forty-nine patients underwent one-stage excisional pro-
cedures. Pre-excision electrocorticography was used to define the epileptogenic zone and resection plane in these patients. Chronic invasive monitoring utilizing implanted subdural electrodes was performed in 100 patients including all cases with normal MRI scans. Completeness of the resection was determined by the epilepsy team composed of neurologists, neuroradiologists, and neurosurgeons at time of surgery and was subsequently confirmed by the authors using primary data. The resection was considered complete only if the region of the structural abnormality (if detected by MRI) and significant EEG abnormalities (defined below) were entirely removed. Resections were judged incomplete if either the structural lesion or the electrographically abnormal region could not be completely excised because of proximity to the eloquent cortex.
The criteria for evaluating intracranial EEG data have been published previously. [23] [24] [25] In patients undergoing intraoperative electrocorticography, regions of active spiking with consistent focality, exhibiting rhythmic features such as trains of focal fast activity, or associated with focal attenuation of background were considered significant and resected. Infrequent spikes and spikes without consistent focality were ignored.
In chronically implanted subjects, the seizure onset zone was the most critical factor in determining the epileptogenic region, especially in patients with normal MRI studies. It was defined as a region exhibiting focal rhythmic activity, bursts of highfrequency discharges, repetitive spiking, or electrodecremental patterns. Secondary foci that consistently activated during seizures were also included in the resection if they occurred in tissue adjacent or in regional proximity to the primary ictal focus. We defined secondary foci as cortical regions evidencing early spread of ictal activity and active independent spiking that were detected during intracranial recordings. Regions of frequent focal interictal spiking and background abnormalities with consistent focality were also considered significant. Slow waves occurring over widespread regions shortly after seizure onset were not regarded as critical for completeness of resection.
Operative complications occurred in 27 subjects and included infections (n ϭ 9), cerebrovascular accidents (n ϭ 4), bleeding (n ϭ 2), brain edema (n ϭ 4), hydrocephalus (n ϭ 1), CSF leak (n ϭ 1), hemiparesis (n ϭ 3), and cranial nerve paresis (n ϭ 3). No subject died after the surgery.
Neuropathologic classification. All neuropathologic findings were reclassified by a neuropathologist (H.V.) and two experienced epileptologists (P.K. and M.D.) according to the current classification scheme. 3, 4 The following mMCD/FCD subcategories were recognized in our series.
Twenty-nine patients had mild malformation of cortical development type II (mMCD) defined by the presence of abundant heterotopic white matter neurons and normal cortical architecture. The presence of a small number of ectopic neurons in the temporal lobe was not regarded as a significant pathologic finding. There were no patients with ectopically placed neurons only in or adjacent to layer 1 in our series (mMCD type I).
Thirty-nine subjects were classified as FCD type Ia because of the presence of cortical dyslamination without cellular abnormalities. A microcolumnar arrangement of cortical neurons was frequently encountered in these patients, usually with an increase in the number of ectopic white matter neurons.
Twenty-nine patients exhibited cortical dyslamination in conjunction with minor cellular abnormalities (giant and immature neurons) and were classified as FCD type Ib.
The histopathologic findings of 28 subjects identified as FCD type IIa were characterized by more pronounced architectural and cytoarchitectural disturbances, especially dysmorphic neurons, but without balloon cells.
Twenty-four patients with FCD type IIb exhibited the same features as the previous group but evidenced balloon cells that are pathognomic for this histopathologic subtype.
Follow-up and outcome. Data regarding seizure outcome and antiepileptic drug treatment were obtained at 2, 5, and 10 years after the last surgery during outpatient visits and telephone contact. Surgical outcome was classified according to Engel's classification scheme: Engel I, completely seizure-free, auras only or only atypical early postoperative seizures; Engel II, Ն90% Seizure outcome in relation to clinical data. Influence of clinical variables and neurologic findings on seizure outcome is shown in table 1. There were no significant differences in seizure outcome between individual subgroups of patients, i.e., no clinical factor was a significant predictor of postsurgical seizure outcome.
Seizure outcome in relation to EEG and MRI features.
The influence of several scalp EEG parameters, MRI findings, and hippocampal pathology on seizure outcome is summarized in table 2. In general, EEG and MRI features were not predictive of postsurgical seizure outcome. We found no evidence of superior outcome for patients with highly localized interictal epileptiform activity and ictal EEG patterns compared to patients with non-regional epileptiform abnormalities. Importantly, there were no differences in seizure outcome between patients with normal and abnormal MRI scans.
Seizure outcome in relation to hippocampal pathology. Fifteen patients had preoperatively detected HS, which was subsequently histopathologically confirmed. Seven more cases had insufficient tissue for pathologic analysis but demonstrated MRI evidence of hippocampal atrophy and signal intensity change. There was no difference in seizure outcome between subjects with and without HS. In order to exclude a possibility that the occurrence of HS modified our results, statistical analysis was done separately for the entire group of patients and after the exclusion of patients with HS. There were no differences between the groups. The values in parentheses are percentages. *p Ͻ 0.0001. †Statistics not done because of small numbers of subjects with multiple subpial transactions.
tions at the time of surgery ( 2 ϭ 52.06, p Ͻ 0.0001). Eight children underwent multiple subpial transections (MST) because of an apparent overlap of the epileptogenic zone and eloquent cortex; their surgical outcomes were poorer in comparison with the entire group of patients. There was a trend toward better outcome in patients undergoing hemispherectomy compared to unilobar and multilobar resections ( 2 ϭ 8.65, p ϭ 0.1935). Other surgical variables did not influence outcome.
Seizure outcome in relation to histopathology. A comparison of surgical outcome and neuropathologic classification of mMCD/FCD is presented in the figure. No differences between individual subgroups of mMCD/FCD were found ( 2 ϭ 11.46, p ϭ 0.4895). However, patients with FCD type IIa and IIb were over-represented in Engel I category while FCD type Ia and Ib subjects were more frequent in the Engel IV group.
Analyses of patients groups in terms of the complete-
ness of surgery. Since completeness of resections was the single significant predictor of surgical outcome, individual variables were re-analyzed in subjects with complete and incomplete resections. There were no clinical, EEG, MRI, surgical, and histopathologic variables different between the groups, except for a higher proportion of subjects with incomplete resec-tions who underwent MST. When reasons for the incomplete resections were analyzed, proximity of the dysplastic cortex to eloquent cortical regions was the most important factor. There were no differences in outcome if incomplete resections were determined by MRI or EEG criteria.
Long-term seizure outcome. Data were available for 113 patients with at least 5 years of postsurgical follow-up, and 10-year follow-up was available in 55 patients. In 85 of 113 patients (75%), seizure outcome remained stable after the second year after the surgery. Three patients became seizure-free between the second and fifth postsurgical year, but none became seizure-free after the fifth postoperative year. Outcome improved (e.g., changed from Engel III to Engel II category) in six subjects after the second postsurgical year. Seizures recurred in 11 patients between the second and fifth postoperative year and in five after the fifth year. The condition worsened (e.g., changed from Engel II to Engel III category) in three patients after the second postoperative year. We found no differences in long-term outcome between subjects with complete and incomplete resections. Individual histopathologic subgroups of mMCD/FCD did not differ in proportions of patients who changed long-term outcomes. However, whereas almost all FCD type II patients who changed outcome after the second postsurgical year either recurred or worsened (10 of 11 patients), significant proportions of changed mMCD and FCD type I patients improved (3 of 8 and 5 of 10). Consequently, minor differences in seizure outcome that were apparent 2 years after the surgery (e.g., better outcome in FCD type II compared with FCD type I patients) disappeared at 5-and 10-year follow-up. Twenty-one patients (14%) were off medication at the end of the follow-up period.
DISCUSSION
Our study was conducted on the largest population of pediatric epilepsy surgery patients with histologically proven FCD to date and demonstrated that complete removal of dysplastic cortex is the single most important predictor of favorable seizure outcome. Seizure freedom was achieved in 70% of patients who had complete resections, but in only 22% with incomplete excision of the dysplastic region. Only 8% of subjects whose resections were judged complete showed no improvement in postoperative seizure frequency compared with 61% of patients after incomplete resections.
Our results support the concept of intrinsic epileptogenicity of dysplastic lesions. 5, 16, 26, 27 It has been suggested that because FCD tissue typically colocalizes with the epileptogenic zone, structural lesion removal is both necessary and sufficient for the achievement of seizure freedom. 5, 19, 26 Different practical approaches have been proposed to delineate dysplastic cortex. We utilized a definition of completeness of surgery based on careful evaluation of both anatomic (MRI) and physiologic (intracranial EEG) data. 19, 21 The reasons for incomplete resections are diverse but overlap of dysplastic and eloquent cortex was clearly the leading cause in our series. Colocalization of FCD with language or motor areas has been repeatedly demonstrated. 20, 28 MST have been proposed as an alternative to resection in this situation, 29 but our experience with this procedure was discouraging. We suggest that a location of mMCD/FCD outside critical cortical areas facilitates their complete removal and remains the most important predictor of postsurgical outcome.
Nevertheless, 22% of our patients who had incomplete surgeries are seizure-free. Similar proportions of "unexpectedly successful surgeries" were noted in other studies examining for completeness of FCD resections. 6, 9, 13, 16, 17, 21 It thus seems likely that the epileptogenic zone may occupy only a portion of dysplastic cortex in some FCD cases. This assumption is in agreement with a recent observation that histopathologic subtypes of FCD are not all equally epileptogenic and that no ictal onsets were found in balloon cells-containing regions. 28 Seizure relief after an incomplete FCD removal remains probably the exception rather than the rule. Nevertheless, this possibility should be analyzed in detail since it might represent a background for "palliative" epilepsy surgery in cases with the overlapping epileptogenic and essential cortical areas.
Unlike several previous reports, we did not find that other presurgical, surgical, and histopathologic parameters (such as early indication for surgery, circumscribed EEG and MRI abnormalities, presurgical intellectual capacities of patients, implantation of intracranial electrodes, extent and location of resections, and histopathologic subtypes of FCD) were predictors of postsurgical seizure outcome. Variations between studies might be due to differences in patient selection, use of diverse classification systems of cortical malformations, short follow-up, or an insufficient number of patients. Another possible explanation includes the diverse clinical, EEG, and imaging spectrum of FCD.
We found that 75% of patients do not change seizure status after the second postoperative year. Late seizure recurrence or worsening of the condition occurred in 17% of subjects with long-term follow-up and were more frequent in FCD type II than in mMCD/FCD type I patients. On the other hand, 8% of patients improved or became seizure-free following the second postoperative year, particularly mMCD/FCD type I patients. Anticonvulsant medication was discontinued in 14% of all patients at the end of follow-up.
Several studies analyzed long-term seizure outcome after surgery for FCD. 6, 11, 18, 21, 22, 30 Two 6,21 reported the same proportion of seizure-free cases at 2 years postoperatively and at the end of long-term follow-up. Two others 18, 30 found that proportion of patients with favorable seizure outcomes decreased (from 84% to 70% and from 67% to 32% during a 10-year period, respectively).
Only 14% of our patients were not taking medication at the end of follow-up. Other series reported that 47% 18 and 32% 30 of patients were off medication. Another study 22 reported that after resection 59% of their FCD subjects were either on monotherapy or medication-free. These differences may reflect diverse approaches in postoperative management of patients among individual epilepsy surgery centers. At our center, AED therapy is tapered or discontinued only if there is seizure freedom for 2 or more years after the surgery, and no significant epileptiform features on the postoperative EEG.
